Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Advances in Brief

  • Advances in Brief
    Human B-Cell Immune Response to the Polymorphic Epithelial Mucin
    Aurelia Rughetti, Valeria Turchi, Cinzia Apollonj Ghetti, Giovanni Scambia, Pierluigi Benedetti Panici, Gabrio Roncucci, Salvatore Mancuso, Luigi Frati and Marianna Nuti
    Cancer Res June 1 1993 53 (11) 2457-2459;

  • Advances in Brief
    Elevated Expression of the Human Mitochondrial Hinge Protein Gene in Cancer
    Alvin Y. Liu and Ragen C. Bradner
    Cancer Res June 1 1993 53 (11) 2460-2465;

  • Advances in Brief
    Effect of Angiotensin II Induced Hypertension on Tumor Blood Flow and Interstitial Fluid Pressure
    Robert A. Zlotecki, Yves Boucher, Intae Lee, Laurence T. Baxter and Rakesh K. Jain
    Cancer Res June 1 1993 53 (11) 2466-2468;

  • Advances in Brief
    Specific Tyrosinases Associated with Melanoma Replicative Senescence and Melanogenesis
    Mary Strasberg Rieber and Manuel Rieber
    Cancer Res June 1 1993 53 (11) 2469-2471;

  • Advances in Brief
    Detection of ras Gene Mutations in Pancreatic Juice and Peripheral Blood of Patients with Pancreatic Adenocarcinoma
    Minoru Tada, Masao Omata, Shigenobu Kawai, Hiromitsu Saisho, Masao Ohto, Randall K. Saiki and John J. Sninsky
    Cancer Res June 1 1993 53 (11) 2472-2474;

  • Advances in Brief
    Characterization of Insulin-like Growth Factor 1 in Human Primary Brain Tumors
    Ann-Christin Sandberg-Nordqvist, Pär-Axel Ståhlbom, Manfred Reinecke, V. Peter Collins, Hans von Holst and Vicki Sara
    Cancer Res June 1 1993 53 (11) 2475-2478;

  • Advances in Brief
    Expression of the Biochemical Defect of Methionine Dependence in Fresh Patient Tumors in Primary Histoculture
    Hui-Yan Guo, Hector Herrera, Ami Groce and Robert M. Hoffman
    Cancer Res June 1 1993 53 (11) 2479-2483;

Articles

  • Advances in Brief
    Human B-Cell Immune Response to the Polymorphic Epithelial Mucin
    Aurelia Rughetti, Valeria Turchi, Cinzia Apollonj Ghetti, Giovanni Scambia, Pierluigi Benedetti Panici, Gabrio Roncucci, Salvatore Mancuso, Luigi Frati and Marianna Nuti
    Cancer Res June 1 1993 53 (11) 2457-2459;

  • Advances in Brief
    Elevated Expression of the Human Mitochondrial Hinge Protein Gene in Cancer
    Alvin Y. Liu and Ragen C. Bradner
    Cancer Res June 1 1993 53 (11) 2460-2465;

  • Advances in Brief
    Effect of Angiotensin II Induced Hypertension on Tumor Blood Flow and Interstitial Fluid Pressure
    Robert A. Zlotecki, Yves Boucher, Intae Lee, Laurence T. Baxter and Rakesh K. Jain
    Cancer Res June 1 1993 53 (11) 2466-2468;

  • Advances in Brief
    Specific Tyrosinases Associated with Melanoma Replicative Senescence and Melanogenesis
    Mary Strasberg Rieber and Manuel Rieber
    Cancer Res June 1 1993 53 (11) 2469-2471;

  • Advances in Brief
    Detection of ras Gene Mutations in Pancreatic Juice and Peripheral Blood of Patients with Pancreatic Adenocarcinoma
    Minoru Tada, Masao Omata, Shigenobu Kawai, Hiromitsu Saisho, Masao Ohto, Randall K. Saiki and John J. Sninsky
    Cancer Res June 1 1993 53 (11) 2472-2474;

  • Advances in Brief
    Characterization of Insulin-like Growth Factor 1 in Human Primary Brain Tumors
    Ann-Christin Sandberg-Nordqvist, Pär-Axel Ståhlbom, Manfred Reinecke, V. Peter Collins, Hans von Holst and Vicki Sara
    Cancer Res June 1 1993 53 (11) 2475-2478;

  • Advances in Brief
    Expression of the Biochemical Defect of Methionine Dependence in Fresh Patient Tumors in Primary Histoculture
    Hui-Yan Guo, Hector Herrera, Ami Groce and Robert M. Hoffman
    Cancer Res June 1 1993 53 (11) 2479-2483;

  • Biochemistry and Biophysics
    Involvement of Protein Kinase C in the Regulation of Glycolipid Sulfotransferase Activity Levels in Renal Cell Carcinoma Cells
    Takahiko Kobayashi, Koichi Honke, Shinsei Gasa, Makoto Sugiura, Tamotsu Miyazaki, Ineo Ishizuka and Akira Makita
    Cancer Res June 1 1993 53 (11) 2484-2489;

  • Biochemistry and Biophysics
    Cyclophosphamide Modulates Rat Hepatic Cytochrome P450 2C11 and Steroid 5α-Reductase Activity and Messenger RNA Levels through the Combined Action of Acrolein and Phosphoramide Mustard
    Thomas K. H. Chang and David J. Waxman
    Cancer Res June 1 1993 53 (11) 2490-2497;

  • Carcinogenesis
    Transplacental Induction of Pancreas Tumors in Hamsters by Ethanol and the Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Hildegard M. Schüller, Rossanna Jorquera, Arthur Reichert and Andre Castonguay
    Cancer Res June 1 1993 53 (11) 2498-2501;

  • Carcinogenesis
    Chemopreventive Effect of Oltipraz during Different Stages of Experimental Colon Carcinogenesis Induced by Azoxymethane in Male F344 Rats
    Chinthalapally V. Rao, Abraham Rivenson, Manish Katiwalla, Gary J. Kelloff and Bandaru S. Reddy
    Cancer Res June 1 1993 53 (11) 2502-2506;

  • Carcinogenesis
    Nonpromoting 12-Deoxyphorbol 13-Esters Inhibit Phorbol 12-Myristate 13-Acetate Induced Tumor Promotion in CD-1 Mouse Skin
    Zoltan Szallasi, Ljubica Krsmanovic and Peter M. Blumberg
    Cancer Res June 1 1993 53 (11) 2507-2512;

  • Clinical Investigations
    High Levels of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Cytosolic Extracts of Breast Carcinomas Are Associated with Poor Prognosis
    Jan Grøndahl-Hansen, Ib Jarle Christensen, Christian Rosenquist, Nils Brünner, Henning T. Mouridsen, Keld Danø and Mogens Blichert-Toft
    Cancer Res June 1 1993 53 (11) 2513-2521;

  • Endocrinology
    Effects of Insulin-like Growth Factor Receptor Inhibition on Human Melanomas in Culture and in Athymic Mice
    Richard W. Furlanetto, Shari E. Harwell and Raymond B. Baggs
    Cancer Res June 1 1993 53 (11) 2522-2526;

  • Endocrinology
    Inhibition of Epidermal Growth Factor-like Growth Factor Secretion in Tracheobronchial Epithelial Cells by Vitamin A
    Lisa A. Miller, Ling Zhong Cheng and Reen Wu
    Cancer Res June 1 1993 53 (11) 2527-2533;

  • Endocrinology
    Antitumor Effect of 22-Oxa-calcitriol, a Noncalcemic Analogue of Calcitriol, in Athymic Mice Implanted with Human Breast Carcinoma and Its Synergism with Tamoxifen
    Junko Abe-Hashimoto, Tomoko Kikuchi, Toshio Matsumoto, Yasuho Nishii, Etsuro Ogata and Kyoji Ikeda
    Cancer Res June 1 1993 53 (11) 2534-2537;

  • Experimental Therapeutics
    Molecular Cloning and Characterization of the Complementary DNA for the Mr 85,000 Protein Overexpressed in Adriamycin-resistant Human Tumor Cells
    Yoshikazu Sugimoto, Hirofumi Hamada, Satomi Tsukahara, Kohji Noguchi, Kazuo Yamaguchi, Moriyuki Sato and Takashi Tsuruo
    Cancer Res June 1 1993 53 (11) 2538-2543;

  • Experimental Therapeutics
    Thaliblastine, a Plant Alkaloid, Circumvents Multidrug Resistance by Direct Binding to P-Glycoprotein
    Guan Chen, Cheppail Ramachandran and Awtar Krishan
    Cancer Res June 1 1993 53 (11) 2544-2547;

  • Experimental Therapeutics
    Effect of Photodynamic Therapy on the Endothelium-dependent Relaxation of Isolated Rat Aortas
    Miriam J. Gilissen, L. Elly A. van de Merbel-de Wit, Willem M. Star, Johan F. Koster and Wim Sluiter
    Cancer Res June 1 1993 53 (11) 2548-2552;

  • Experimental Therapeutics
    Inhibition of Urokinase by 4-substituted Benzo[b]thiophene-2-carboxamidines: An Important New Class of Selective Synthetic Urokinase Inhibitor
    Murray J. Towle, Arthur Lee, Emmanuel C. Maduakor, C. Eric Schwartz, Alexander J. Bridges and Bruce A. Littlefield
    Cancer Res June 1 1993 53 (11) 2553-2559;

  • Experimental Therapeutics
    Monoclonal Antibody Homodimers: Enhanced Antitumor Activity in Nude Mice
    Edith A. Wolff, George J. Schreiber, Wesley L. Cosand and Howard V. Raff
    Cancer Res June 1 1993 53 (11) 2560-2565;

  • Experimental Therapeutics
    Inhibitory Effect of Angiogenesis Inhibitor TNP-470 on Tumor Growth and Metastasis of Human Cell Lines in Vitro and in Vivo
    Toru Yanase, Masaki Tamura, Kazuyuki Fujita, Shoji Kodama and Kenichi Tanaka
    Cancer Res June 1 1993 53 (11) 2566-2570;

  • Experimental Therapeutics
    Phototoxicity, Redox Behavior, and Pharmacokinetics of Benzophenoxazine Analogues in EMT-6 Murine Sarcoma Cells
    Louis Cincotta, James W. Foley and Anthony H. Cincotta
    Cancer Res June 1 1993 53 (11) 2571-2580;

  • Experimental Therapeutics
    Preclinical Antitumor Evaluation of Bis-acetato-ammine-dichloro-cyclohexylamine Platinum(IV): an Orally Active Platinum Drug
    Lloyd R. Kelland, George Abel, Mark J. McKeage, Mervyn Jones, Phyllis M. Goddard, Melanie Valenti, Barry A. Murrer and Kenneth R. Harrap
    Cancer Res June 1 1993 53 (11) 2581-2586;

  • Experimental Therapeutics
    Pharmacokinetics of Piroxantrone in a Phase I Trial of Piroxantrone and Granulocyte-Colony Stimulating Factor
    Stacey L. Berg, Diane M. F. Savarese, Frank M. Balis, Andrea M. Denicoff, Marianne Hillig, Joyce A. O'Shaughnessy, David G. Poplack and Kenneth H. Cowan
    Cancer Res June 1 1993 53 (11) 2587-2590;

  • Experimental Therapeutics
    Overcoming Tumor Necrosis Factor and Drug Resistance of Human Tumor Cell Lines by Combination Treatment with Anti-Fas Antibody and Drugs or Toxins
    Hideki Morimoto, Shin Yonehara and Benjamin Bonavida
    Cancer Res June 1 1993 53 (11) 2591-2596;

  • Experimental Therapeutics
    Human Interleukin 2 Analogues That Preferentially Bind the Intermediate-Affinity Interleukin 2 Receptor Lead to Reduced Secondary Cytokine Secretion: Implications for the Use of These Interleukin 2 Analogues in Cancer Immunotherapy
    Keith M. Heaton, Grace Ju and Elizabeth A. Grimm
    Cancer Res June 1 1993 53 (11) 2597-2602;

  • Experimental Therapeutics
    Cytokine Regulation of Human Monocyte Differentiation in Vitro: The Tumor-Cytotoxic Phenotype Induced by Macrophage Colony-stimulating Factor Is Developmentally Regulated by γ-Interferon
    David H. Munn and Elissa Armstrong
    Cancer Res June 1 1993 53 (11) 2603-2613;

  • Experimental Therapeutics
    Base Transitions Are the Most Frequent Genetic Changes at P53 in Gastric Cancer
    Beatrice Renault, Marianne van den Broek, Riccardo Fodde, Juul Wijnen, Natalia S. Pellegata, Dino Amadori, P. Meera Khan and Guglielmina N. Ranzani
    Cancer Res June 1 1993 53 (11) 2614-2617;

  • Experimental Therapeutics
    Transformation of NIH/3T3 Cells by Ornithine Decarboxylase Overexpression
    Jeffrey A. Moshier, Julie Dosescu, Magdalena Skunca and Gordon D. Luk
    Cancer Res June 1 1993 53 (11) 2618-2622;

  • Experimental Therapeutics
    Sensitization of Tumor Cells to Tumor Necrosis Factor Action by the Protein Kinase Inhibitor Staurosporine
    Rudi Beyaert, Bart Vanhaesebroeck, Karen Heyninck, Elke Boone, Dirk De Valck, Klaus Schulze-Osthoff, Guy Haegeman, Frans Van Roy and Walter Fiers
    Cancer Res June 1 1993 53 (11) 2623-2630;

  • Experimental Therapeutics
    Pathogenesis of Malignant Ascites Formation: Initiating Events That Lead to Fluid Accumulation
    Janice A. Nagy, Kemp T. Herzberg, Jane M. Dvorak and Harold F. Dvorak
    Cancer Res June 1 1993 53 (11) 2631-2643;

  • Experimental Therapeutics
    Culture of Normal and Malignant Primary Human Mammary Epithelial Cells in a Physiological Manner Simulates in Vivo Growth Patterns and Allows Discrimination of Cell Type
    Lynn M. Bergstraesser and Sigmund A. Weitzman
    Cancer Res June 1 1993 53 (11) 2644-2654;

  • Experimental Therapeutics
    Elevated High Mobility Group-I(Y) Gene Expression Is Associated with Progressive Transformation of Mouse Mammary Epithelial Cells
    Tracy G. Ram, Raymond Reeves and Howard L. Hosick
    Cancer Res June 1 1993 53 (11) 2655-2660;

  • Experimental Therapeutics
    Laminin Regulates a Tumor Cell Chemotaxis Receptor through the Laminin-binding Integrin Subunit α6
    Christine H. Blood and Bruce R. Zetter
    Cancer Res June 1 1993 53 (11) 2661-2666;

  • Experimental Therapeutics
    Galaptin-mediated Adhesion of Human Ovarian Carcinoma A121 Cells and Detection of Cellular Galaptin-binding Glycoproteins
    David M. Skrincosky, Howard J. Allen and Ralph J. Bernacki
    Cancer Res June 1 1993 53 (11) 2667-2675;

  • Experimental Therapeutics
    Nitric Oxide Mediates Kupffer Cell-induced Reduction of Mitochondrial Energization in Hepatoma Cells: A Comparison with Oxidative Burst
    Iwao Kurose, Soichiro Miura, Dai Fukumura, Yoshikazu Yonei, Hidetsugu Saito, Shinichiro Tada, Makoto Suematsu and Masaharu Tsuchiya
    Cancer Res June 1 1993 53 (11) 2676-2682;

  • Meeting Report
    Second International Symposium on Cytostatic Drug Resistance
    Manfred Dietel
    Cancer Res June 1 1993 53 (11) 2683-2688;

  • Meeting Report
    International Symposium on Polyamines in Cancer
    Kenji Nishioka
    Cancer Res June 1 1993 53 (11) 2689-2692;

  • Articles
    Announcements
    Cancer Res June 1 1993 53 (11) 2693-2694;

  • Articles
    Recent Deaths
    Cancer Res June 1 1993 53 (11) 2694-2694;

  • Articles
    Calendar of Events
    Cancer Res June 1 1993 53 (11) 2694-2695;

Biochemistry and Biophysics

  • Biochemistry and Biophysics
    Involvement of Protein Kinase C in the Regulation of Glycolipid Sulfotransferase Activity Levels in Renal Cell Carcinoma Cells
    Takahiko Kobayashi, Koichi Honke, Shinsei Gasa, Makoto Sugiura, Tamotsu Miyazaki, Ineo Ishizuka and Akira Makita
    Cancer Res June 1 1993 53 (11) 2484-2489;

  • Biochemistry and Biophysics
    Cyclophosphamide Modulates Rat Hepatic Cytochrome P450 2C11 and Steroid 5α-Reductase Activity and Messenger RNA Levels through the Combined Action of Acrolein and Phosphoramide Mustard
    Thomas K. H. Chang and David J. Waxman
    Cancer Res June 1 1993 53 (11) 2490-2497;

Carcinogenesis

  • Carcinogenesis
    Transplacental Induction of Pancreas Tumors in Hamsters by Ethanol and the Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Hildegard M. Schüller, Rossanna Jorquera, Arthur Reichert and Andre Castonguay
    Cancer Res June 1 1993 53 (11) 2498-2501;

  • Carcinogenesis
    Chemopreventive Effect of Oltipraz during Different Stages of Experimental Colon Carcinogenesis Induced by Azoxymethane in Male F344 Rats
    Chinthalapally V. Rao, Abraham Rivenson, Manish Katiwalla, Gary J. Kelloff and Bandaru S. Reddy
    Cancer Res June 1 1993 53 (11) 2502-2506;

  • Carcinogenesis
    Nonpromoting 12-Deoxyphorbol 13-Esters Inhibit Phorbol 12-Myristate 13-Acetate Induced Tumor Promotion in CD-1 Mouse Skin
    Zoltan Szallasi, Ljubica Krsmanovic and Peter M. Blumberg
    Cancer Res June 1 1993 53 (11) 2507-2512;

Clinical Investigations

  • Clinical Investigations
    High Levels of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Cytosolic Extracts of Breast Carcinomas Are Associated with Poor Prognosis
    Jan Grøndahl-Hansen, Ib Jarle Christensen, Christian Rosenquist, Nils Brünner, Henning T. Mouridsen, Keld Danø and Mogens Blichert-Toft
    Cancer Res June 1 1993 53 (11) 2513-2521;

Endocrinology

  • Endocrinology
    Effects of Insulin-like Growth Factor Receptor Inhibition on Human Melanomas in Culture and in Athymic Mice
    Richard W. Furlanetto, Shari E. Harwell and Raymond B. Baggs
    Cancer Res June 1 1993 53 (11) 2522-2526;

  • Endocrinology
    Inhibition of Epidermal Growth Factor-like Growth Factor Secretion in Tracheobronchial Epithelial Cells by Vitamin A
    Lisa A. Miller, Ling Zhong Cheng and Reen Wu
    Cancer Res June 1 1993 53 (11) 2527-2533;

  • Endocrinology
    Antitumor Effect of 22-Oxa-calcitriol, a Noncalcemic Analogue of Calcitriol, in Athymic Mice Implanted with Human Breast Carcinoma and Its Synergism with Tamoxifen
    Junko Abe-Hashimoto, Tomoko Kikuchi, Toshio Matsumoto, Yasuho Nishii, Etsuro Ogata and Kyoji Ikeda
    Cancer Res June 1 1993 53 (11) 2534-2537;

Experimental Therapeutics

  • Experimental Therapeutics
    Molecular Cloning and Characterization of the Complementary DNA for the Mr 85,000 Protein Overexpressed in Adriamycin-resistant Human Tumor Cells
    Yoshikazu Sugimoto, Hirofumi Hamada, Satomi Tsukahara, Kohji Noguchi, Kazuo Yamaguchi, Moriyuki Sato and Takashi Tsuruo
    Cancer Res June 1 1993 53 (11) 2538-2543;

  • Experimental Therapeutics
    Thaliblastine, a Plant Alkaloid, Circumvents Multidrug Resistance by Direct Binding to P-Glycoprotein
    Guan Chen, Cheppail Ramachandran and Awtar Krishan
    Cancer Res June 1 1993 53 (11) 2544-2547;

  • Experimental Therapeutics
    Effect of Photodynamic Therapy on the Endothelium-dependent Relaxation of Isolated Rat Aortas
    Miriam J. Gilissen, L. Elly A. van de Merbel-de Wit, Willem M. Star, Johan F. Koster and Wim Sluiter
    Cancer Res June 1 1993 53 (11) 2548-2552;

  • Experimental Therapeutics
    Inhibition of Urokinase by 4-substituted Benzo[b]thiophene-2-carboxamidines: An Important New Class of Selective Synthetic Urokinase Inhibitor
    Murray J. Towle, Arthur Lee, Emmanuel C. Maduakor, C. Eric Schwartz, Alexander J. Bridges and Bruce A. Littlefield
    Cancer Res June 1 1993 53 (11) 2553-2559;

  • Experimental Therapeutics
    Monoclonal Antibody Homodimers: Enhanced Antitumor Activity in Nude Mice
    Edith A. Wolff, George J. Schreiber, Wesley L. Cosand and Howard V. Raff
    Cancer Res June 1 1993 53 (11) 2560-2565;

  • Experimental Therapeutics
    Inhibitory Effect of Angiogenesis Inhibitor TNP-470 on Tumor Growth and Metastasis of Human Cell Lines in Vitro and in Vivo
    Toru Yanase, Masaki Tamura, Kazuyuki Fujita, Shoji Kodama and Kenichi Tanaka
    Cancer Res June 1 1993 53 (11) 2566-2570;

  • Experimental Therapeutics
    Phototoxicity, Redox Behavior, and Pharmacokinetics of Benzophenoxazine Analogues in EMT-6 Murine Sarcoma Cells
    Louis Cincotta, James W. Foley and Anthony H. Cincotta
    Cancer Res June 1 1993 53 (11) 2571-2580;

  • Experimental Therapeutics
    Preclinical Antitumor Evaluation of Bis-acetato-ammine-dichloro-cyclohexylamine Platinum(IV): an Orally Active Platinum Drug
    Lloyd R. Kelland, George Abel, Mark J. McKeage, Mervyn Jones, Phyllis M. Goddard, Melanie Valenti, Barry A. Murrer and Kenneth R. Harrap
    Cancer Res June 1 1993 53 (11) 2581-2586;

  • Experimental Therapeutics
    Pharmacokinetics of Piroxantrone in a Phase I Trial of Piroxantrone and Granulocyte-Colony Stimulating Factor
    Stacey L. Berg, Diane M. F. Savarese, Frank M. Balis, Andrea M. Denicoff, Marianne Hillig, Joyce A. O'Shaughnessy, David G. Poplack and Kenneth H. Cowan
    Cancer Res June 1 1993 53 (11) 2587-2590;

  • Experimental Therapeutics
    Overcoming Tumor Necrosis Factor and Drug Resistance of Human Tumor Cell Lines by Combination Treatment with Anti-Fas Antibody and Drugs or Toxins
    Hideki Morimoto, Shin Yonehara and Benjamin Bonavida
    Cancer Res June 1 1993 53 (11) 2591-2596;

  • Experimental Therapeutics
    Human Interleukin 2 Analogues That Preferentially Bind the Intermediate-Affinity Interleukin 2 Receptor Lead to Reduced Secondary Cytokine Secretion: Implications for the Use of These Interleukin 2 Analogues in Cancer Immunotherapy
    Keith M. Heaton, Grace Ju and Elizabeth A. Grimm
    Cancer Res June 1 1993 53 (11) 2597-2602;

  • Experimental Therapeutics
    Cytokine Regulation of Human Monocyte Differentiation in Vitro: The Tumor-Cytotoxic Phenotype Induced by Macrophage Colony-stimulating Factor Is Developmentally Regulated by γ-Interferon
    David H. Munn and Elissa Armstrong
    Cancer Res June 1 1993 53 (11) 2603-2613;

  • Experimental Therapeutics
    Base Transitions Are the Most Frequent Genetic Changes at P53 in Gastric Cancer
    Beatrice Renault, Marianne van den Broek, Riccardo Fodde, Juul Wijnen, Natalia S. Pellegata, Dino Amadori, P. Meera Khan and Guglielmina N. Ranzani
    Cancer Res June 1 1993 53 (11) 2614-2617;

  • Experimental Therapeutics
    Transformation of NIH/3T3 Cells by Ornithine Decarboxylase Overexpression
    Jeffrey A. Moshier, Julie Dosescu, Magdalena Skunca and Gordon D. Luk
    Cancer Res June 1 1993 53 (11) 2618-2622;

  • Experimental Therapeutics
    Sensitization of Tumor Cells to Tumor Necrosis Factor Action by the Protein Kinase Inhibitor Staurosporine
    Rudi Beyaert, Bart Vanhaesebroeck, Karen Heyninck, Elke Boone, Dirk De Valck, Klaus Schulze-Osthoff, Guy Haegeman, Frans Van Roy and Walter Fiers
    Cancer Res June 1 1993 53 (11) 2623-2630;

  • Experimental Therapeutics
    Pathogenesis of Malignant Ascites Formation: Initiating Events That Lead to Fluid Accumulation
    Janice A. Nagy, Kemp T. Herzberg, Jane M. Dvorak and Harold F. Dvorak
    Cancer Res June 1 1993 53 (11) 2631-2643;

  • Experimental Therapeutics
    Culture of Normal and Malignant Primary Human Mammary Epithelial Cells in a Physiological Manner Simulates in Vivo Growth Patterns and Allows Discrimination of Cell Type
    Lynn M. Bergstraesser and Sigmund A. Weitzman
    Cancer Res June 1 1993 53 (11) 2644-2654;

  • Experimental Therapeutics
    Elevated High Mobility Group-I(Y) Gene Expression Is Associated with Progressive Transformation of Mouse Mammary Epithelial Cells
    Tracy G. Ram, Raymond Reeves and Howard L. Hosick
    Cancer Res June 1 1993 53 (11) 2655-2660;

  • Experimental Therapeutics
    Laminin Regulates a Tumor Cell Chemotaxis Receptor through the Laminin-binding Integrin Subunit α6
    Christine H. Blood and Bruce R. Zetter
    Cancer Res June 1 1993 53 (11) 2661-2666;

  • Experimental Therapeutics
    Galaptin-mediated Adhesion of Human Ovarian Carcinoma A121 Cells and Detection of Cellular Galaptin-binding Glycoproteins
    David M. Skrincosky, Howard J. Allen and Ralph J. Bernacki
    Cancer Res June 1 1993 53 (11) 2667-2675;

  • Experimental Therapeutics
    Nitric Oxide Mediates Kupffer Cell-induced Reduction of Mitochondrial Energization in Hepatoma Cells: A Comparison with Oxidative Burst
    Iwao Kurose, Soichiro Miura, Dai Fukumura, Yoshikazu Yonei, Hidetsugu Saito, Shinichiro Tada, Makoto Suematsu and Masaharu Tsuchiya
    Cancer Res June 1 1993 53 (11) 2676-2682;

Meeting Report

  • Meeting Report
    Second International Symposium on Cytostatic Drug Resistance
    Manfred Dietel
    Cancer Res June 1 1993 53 (11) 2683-2688;

  • Meeting Report
    International Symposium on Polyamines in Cancer
    Kenji Nishioka
    Cancer Res June 1 1993 53 (11) 2689-2692;

Back to top
PreviousNext
June 1993
Volume 53, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Jump to

  • Advances in Brief
  • Articles
  • Biochemistry and Biophysics
  • Carcinogenesis
  • Clinical Investigations
  • Endocrinology
  • Experimental Therapeutics
  • Meeting Report
Advertisement
  • Most Cited
  • Most Read
Loading
  • Towards Multidrug Adaptive Therapy
  • MEK Inhibition Synergizes with Statins for Cancer Treatment
  • IL1β Promotes Immune Suppression in Pancreatic Cancer
  • Multiple Primary Cancer Penetrance for TP53
  • Metabolomic Gradients in Glioblastoma Models
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement